Qiagen Posts 10-Percent Q2 Organic Revenue Growth as Profit Rises 3 Percent | GenomeWeb
NEW YORK (GenomeWeb News) – Qiagen yesterday said second-quarter revenues rose 13 percent, 10 percent of which was organic growth, while the company’s net profit increased 3 percent.
 
Receipts for the second quarter increased to $113.2 million from $100.4 million in the same quarter last year. Approximately 10 percent of this was organic and acquisitions contributed about 3 percent, Qiagen said. 
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.